Myo-inositol (MYO) represents usually a therapeutic option for female infertility associated with insulin resistance. Recently, several evidences are accumulating about the potential use of MYO for the treatment of male infertility. This article summarizes the rationale for MYO in the treatment of male infertility. In particular, it illustrates the potential antioxidant and prokinetic role of MYO, and its importance for the modulation of hormonal regulation. In the final part of the manuscript has been added a proposal for a clinical algorithm reserved for patients with asthenozoospermia, where probably MYO could exert specific pharmacological effects
Myo-inositol as a male fertility molecule: speed them up!
CONDORELLI, ROSITA ANGELA;LA VIGNERA, SANDRO SALVUCCIO MARIA;MONGIOI', LAURA MARIA;VITALE, SALVATORE GIOVANNI;CIMINO, LAURA;CALOGERO, Aldo Eugenio
2017-01-01
Abstract
Myo-inositol (MYO) represents usually a therapeutic option for female infertility associated with insulin resistance. Recently, several evidences are accumulating about the potential use of MYO for the treatment of male infertility. This article summarizes the rationale for MYO in the treatment of male infertility. In particular, it illustrates the potential antioxidant and prokinetic role of MYO, and its importance for the modulation of hormonal regulation. In the final part of the manuscript has been added a proposal for a clinical algorithm reserved for patients with asthenozoospermia, where probably MYO could exert specific pharmacological effects| File | Dimensione | Formato | |
|---|---|---|---|
|
374_Condorelli_Eur-Rev-Med-Pharmacol-Sci_2017_proof.pdf
accesso aperto
Tipologia:
Documento in Pre-print
Dimensione
671.18 kB
Formato
Adobe PDF
|
671.18 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
